Concert Pharmaceuticals Short Interest Ratio and Short Volume

Short interest is the volume of Concert Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,140,000 shares of CNCE short.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Concert Pharmaceuticals currently has a short interest ratio of 2.0.

Concert Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,140,000 shares, an increase of 46.2% from the previous total of 779,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Concert Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Concert Pharmaceuticals: Verastem, Inc. (0.00%), Altimmune, Inc. (0.00%), Basilea Pharmaceutica AG (0.00%), Viking Therapeutics, Inc. (16.13%), Athenex, Inc. (16.83%), Neoleukin Therapeutics, Inc. (0.00%), Hookipa Pharma Inc (0.00%), Geron Co. (0.00%), Provention Bio, Inc. (0.00%), and AC Immune SA (3.32%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling CNCE is an investing strategy that aims to generate trading profit from Concert Pharmaceuticals as its price is falling. Concert Pharmaceuticals' stock is trading up $0.06 today. To short Concert Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Concert Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Concert Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNCE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNCE, twice per month. The most recent reporting period available is April, 15 2021.